Endoscopic Variceal Ligation Plus Nadolol and Sucralfate Compared With Ligation Alone for the Prevention of Variceal Rebleeding: A Prospective, Randomized Trial-Reference-Cited by-同舟云学术

Endoscopic Variceal Ligation Plus Nadolol and Sucralfate Compared With Ligation Alone for the Prevention of Variceal Rebleeding: A Prospective, Randomized Trial

Published:2000-09 Issue:3 Volume:32 Page:461-465
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Lo Gin-Ho,Lai Kwok-Hung,Cheng Jin-Shiung,Chen Mei-Hsiu,Huang Hui-Chun,Hsu Ping-I,Lin Chiun-Ku

Publisher

Wiley

Subject

Hepatology

Reference35 articles.

1. The course of patients after variceal hemorrhage

2. Endoscopic Sclerotherapy as Compared with Endoscopic Ligation for Bleeding Esophageal Varices

3. Endoscopic Ligation Compared with Sclerotherapy for the Treatment of Bleeding Esophageal Varices

4. Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices

5. A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices

Cited by 234 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carvedilol and Traditional Nonselective Beta Blockers for the Secondary Prophylaxis of Variceal Hemorrhage and Portal Hypertension Related Complications Among Patients with Decompensated Cirrhosis: A Systematic Review and Network Meta-Analysis;2024

2. A Randomized Controlled Trial of Propranolol Use During Ligation Program for Secondary Prophylaxis of Esophageal Variceal Bleeding;American Journal of Gastroenterology;2023-09-11

3. Non-selective beta-blockers and the incidence of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis;Frontiers in Pharmacology;2023-07-19

4. Letter to the Editor: Is embolization of large spontaneous shunt effective in the prevention of HE after TIPS?;Hepatology;2023-02-03

5. Reply to: ‘Management of portal hypertension in patients treated with atezolizumab and bevacizumab for hepatocellular carcinoma’;Journal of Hepatology;2022-08